Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An announcement from Lexicon Pharmaceuticals (LXRX) is now available.
Lonnel Coats has announced his retirement as the CEO and board member of Lexicon Pharmaceuticals, effective from July 7, 2024. Following his departure, the company has begun the process of finding a successor, considering both internal and external candidates, to lead the organization into the future.
For an in-depth examination of LXRX stock, go to TipRanks’ Stock Analysis page.